pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,915 catalysts · 3,312 8k filing · 1,702 grant · 1,000 device adverse event · 795 approval · 621 device 510k · 584 earnings

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 0 catalysts2026-08-14: 28 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-02-06×clear all
type
  • 8k filing3,312
  • grant1,702
  • device adverse event1,000
  • approval795
  • device 510k621
  • earnings584
device pma
467
  • device recall191
  • phase 2 completion172
  • recall162
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Mar 2, 2026

    50
    ›Mar 2, 2026device pma166d agoAlcon Laboratories, Inc. — AcrySof® Posterior Chamber Intraocular Lens and Delivery Systems (PMA supplement)Alcon Laboratories Inc

    Supplement type: 30-Day Notice. Product code: HQL. Advisory committee: OP. Decision: OK30

    full page →fda device pma ↗
    ›Mar 2, 2026device pma166d agoEndotronix, Inc. — Cordella Pulmonary Artery Sensor System (CorPASS) (PMA supplement)

    Supplement type: 30-Day Notice. Product code: MOM. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Mar 2, 2026device pma166d agoAlcon Research, Ltd. — AcrySof® IQ ReSTOR Posterior Chamber Intraocular Lenses (PMA supplement)Rubicon Research Ltd

    Supplement type: 30-Day Notice. Product code: MFK. Advisory committee: OP. Decision: OK30

    full page →fda device pma ↗
    ›Mar 2, 2026device pma166d agoMicroTransponder, Inc. — Vivistim® System (PMA supplement)

    Supplement type: 30-Day Notice. Product code: QPY. Advisory committee: PM. Decision: OK30

    full page →fda device pma ↗
    ›Mar 2, 2026device pma166d agoAbbott Vascular, Inc. — Perclose ProGlide™ Suture-Mediated Closure System; Perclose™ ProStyle™ Suture-Mediated Closure and Repair System (PMA supplement)

    Supplement type: 30-Day Notice. Product code: MGB. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Mar 2, 2026device pma166d agoAbbott Vascular Devices — StarClose SE™ Vascular Closure System (PMA supplement)

    Supplement type: 30-Day Notice. Product code: MGB. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Mar 2, 2026device pma166d agoAlcon Laboratories, LLC — Clareon® Aspheric Hydrophobic Acrylic Intraocular Lens (IOL) and Clareon® PanOptix Hydrophobic Acrylic IOL (PMA supplement)Alcon Laboratories Inc

    Supplement type: 30-Day Notice. Product code: HQL. Advisory committee: OP. Decision: OK30

    full page →fda device pma ↗
    ›Mar 2, 2026device recall166d agoCivco Medical Instruments Co. Inc. device recall (Cls II)

    eTRAX Needle System Starter Kit 18G (for Aurora Trackers), Part Number 667-152 — Reason: There was an error in inspection and programming of the eTRAX needle sensor for Aurora trackers. The result is a potential for the needle tip position to be incorrectly identified on the user interface. — Status: Ongoing

    full page →fda device recalls ↗
    ›Mar 2, 2026device recall166d agoPhilips Respironics, Inc. device recall (Cls I)

    Philips Respironics Trilogy Evo Universal, Software Version 1.05.15.00. Continuous home-use ventilator device. — Reason: Using non-pneumatic nebulizers with Trilogy Evo Platform ventilators may result in a discrepancy between the set tidal volume and the tidal volume received by the patient. — Status: Ongoing

    full page →fda device recalls ↗
    ›Mar 2, 2026device recall166d agoPhilips Respironics, Inc. device recall (Cls I)

    Philips Respironics Trilogy EV300, Software Version 1.05.15.00. Continuous home-use ventilator device. — Reason: Using non-pneumatic nebulizers with Trilogy Evo Platform ventilators may result in a discrepancy between the set tidal volume and the tidal volume received by the patient. — Status: Ongoing

    full page →fda device recalls ↗
    ›Mar 2, 2026device recall166d agoCivco Medical Instruments Co. Inc. device recall (Cls II)

    eTRAX Needle Sensor - 18G (for Aurora Trackers), Part Number 667-159 — Reason: There was an error in inspection and programming of the eTRAX needle sensor for Aurora trackers. The result is a potential for the needle tip position to be incorrectly identified on the user interface. — Status: Ongoing

    full page →fda device recalls ↗
    ›Mar 2, 2026device recall166d agoCivco Medical Instruments Co. Inc. device recall (Cls II)

    eTRAX Needle System Starter Kit 16G(for Aurora Trackers), Part Number 667-151 — Reason: There was an error in inspection and programming of the eTRAX needle sensor for Aurora trackers. The result is a potential for the needle tip position to be incorrectly identified on the user interface. — Status: Ongoing

    full page →fda device recalls ↗
    ›Mar 2, 2026device recall166d agoCivco Medical Instruments Co. Inc. device recall (Cls II)

    eTRAX Needle Sensor - 14G(for Aurora Trackers), Part Number 667-157 — Reason: There was an error in inspection and programming of the eTRAX needle sensor for Aurora trackers. The result is a potential for the needle tip position to be incorrectly identified on the user interface. — Status: Ongoing

    full page →fda device recalls ↗
    ›Mar 2, 2026device recall166d agoCivco Medical Instruments Co. Inc. device recall (Cls II)

    eTRAX Needle System Starter Kit 14G (for Aurora Trackers), Part Number 667-150 — Reason: There was an error in inspection and programming of the eTRAX needle sensor for Aurora trackers. The result is a potential for the needle tip position to be incorrectly identified on the user interface. — Status: Ongoing

    full page →fda device recalls ↗
    ›Mar 2, 2026device recall166d agoPhilips Respironics, Inc. device recall (Cls I)

    Philips Respironics Trilogy Evo O2, Software Version 1.05.15.00. Continuous home-use ventilator device. — Reason: Using non-pneumatic nebulizers with Trilogy Evo Platform ventilators may result in a discrepancy between the set tidal volume and the tidal volume received by the patient. — Status: Ongoing

    full page →fda device recalls ↗
    ›Mar 2, 2026device recall166d agoCivco Medical Instruments Co. Inc. device recall (Cls II)

    eTRAX Needle Sensor - 12G (for Aurora Trackers), Part Number 667-156 — Reason: There was an error in inspection and programming of the eTRAX needle sensor for Aurora trackers. The result is a potential for the needle tip position to be incorrectly identified on the user interface. — Status: Ongoing

    full page →fda device recalls ↗
    ›Mar 2, 2026device recall166d agoPhilips Respironics, Inc. device recall (Cls I)

    Philips Respironics Trilogy Evo O2, Software Version 1.05.15.00. Continuous home-use ventilator device. — Reason: In some situations, the Obstruction Alarm does not trigger within the timeframe dictated by the relevant standards and may take up to four breaths. — Status: Ongoing

    full page →fda device recalls ↗
    ›Mar 2, 2026device recall166d agoPhilips Respironics, Inc. device recall (Cls I)

    Philips Respironics Trilogy Evo Universal, Software Version 1.05.15.00. Continuous home-use ventilator device. — Reason: In some situations, the Obstruction Alarm does not trigger within the timeframe dictated by the relevant standards and may take up to four breaths. — Status: Ongoing

    full page →fda device recalls ↗
    ›Mar 2, 2026device recall166d agoCivco Medical Instruments Co. Inc. device recall (Cls II)

    eTRAX Needle Sensor - 16G(for Aurora Trackers), Part Number 667-158 — Reason: There was an error in inspection and programming of the eTRAX needle sensor for Aurora trackers. The result is a potential for the needle tip position to be incorrectly identified on the user interface. — Status: Ongoing

    full page →fda device recalls ↗
    ›Mar 2, 2026device recall166d agoPhilips Respironics, Inc. device recall (Cls I)

    Philips Respironics Trilogy EV300, Software Version 1.05.15.00. Continuous home-use ventilator device. — Reason: In some situations, the Obstruction Alarm does not trigger within the timeframe dictated by the relevant standards and may take up to four breaths. — Status: Ongoing

    full page →fda device recalls ↗
    ›Mar 2, 2026device recall166d agoCivco Medical Instruments Co. Inc. device recall (Cls II)

    eTRAX Needle System Starter Kit 12G (for Aurora Trackers), Part Number 667-149 — Reason: There was an error in inspection and programming of the eTRAX needle sensor for Aurora trackers. The result is a potential for the needle tip position to be incorrectly identified on the user interface. — Status: Ongoing

    full page →fda device recalls ↗
    ›Mar 2, 2026device recall166d agoPhilips Respironics, Inc. device recall (Cls I)

    Philips Respironics Trilogy Evo, Software Version 1.05.15.00. Continuous home-use ventilator device. — Reason: In some situations, the Obstruction Alarm does not trigger within the timeframe dictated by the relevant standards and may take up to four breaths. — Status: Ongoing

    full page →fda device recalls ↗
    ›Mar 2, 2026device recall166d agoPhilips Respironics, Inc. device recall (Cls I)

    Philips Respironics Trilogy Evo, Software Version 1.05.15.00. Continuous home-use ventilator device. — Reason: Using non-pneumatic nebulizers with Trilogy Evo Platform ventilators may result in a discrepancy between the set tidal volume and the tidal volume received by the patient. — Status: Ongoing

    full page →fda device recalls ↗
    ›Mar 2, 2026grant166d agoTEXAS A&M AGRILIFE RESEARCH — NAMs-Decisions Center: New Approach Methods for Decisions on Industrial and C...

    TR grant. $3,124,604. PI: Ivan Rusyn

    full page →nih reporter ↗
    ›Mar 2, 2026grant166d agoOREGON HEALTH & SCIENCE UNIVERSITY — Optimizing cAMP and PKA sensors for cell-specific dissection of neuronal circ...

    MH grant. $2,039,804. PI: Isabelle Rhyssa Joe Eduria Baconguis

    full page →nih reporter ↗
    ›Mar 2, 2026grant166d agoUNIVERSITY OF PENNSYLVANIA — Harnessing XNAs to Expand the Genetic Toolkit for RNA Silencing and RNA editingUniversity of Pennsylvania

    GM grant. $406,250. PI: LIJUN ZHOU

    full page →nih reporter ↗
    ›Mar 2, 2026grant166d agoNORTHEASTERN UNIVERSITY — Integrated mass spectrometry strategies to decipher metabolite-protein cross ...

    GM grant. $434,000. PI: Owen Samuel Skinner

    full page →nih reporter ↗
    ›Mar 2, 2026grant166d agoUNIVERSITY OF COLORADO DENVER — Classification of Disease Associated B Cell Receptors in Multiple SclerosisUniversity of Colorado Denver

    NS grant. $427,712. PI: WENDY B MACKLIN

    full page →nih reporter ↗
    ›Mar 2, 2026grant166d agoIOWA STATE UNIVERSITY — Transcriptome- and proteome-wide effects of circular RNAs of SMA genes

    NS grant. $420,750. PI: RAVINDRA N SINGH

    full page →nih reporter ↗
    ›Mar 2, 2026grant166d agoUTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH — Development and Application of Nicotinic Acetylcholine Receptor Targeted Pept...University of Utah

    GM grant. $500,500. PI: J MICHAEL MCINTOSH

    full page →nih reporter ↗
    ›Mar 2, 2026grant166d agoNEW YORK UNIVERSITY — Replay-Driven Task Orthogonalization and Abstraction for Continual LearningNew York University

    MH grant. $75,052. PI: Zhenglong Zhou

    full page →nih reporter ↗
    ›Mar 3, 2026approval165d agoBOSENTAN — FDA approvalBOSENTAN

    Sponsor: WATSON LABS INC. Form: TABLET. Route: ORAL

    full page →BOSENTAN →fda approvals ↗
    ›Mar 3, 2026approval165d agoBOSENTAN — FDA approvalZydus Therapeutics Inc

    Sponsor: ZYDUS PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 3, 2026approval165d agoBOSENTAN — FDA approvalJanssen-Cilag Holdings Inc (Inactive)

    Sponsor: SUN PHARM. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 3, 2026approval165d agoBOSENTAN — FDA approvalZydus Therapeutics Inc

    Sponsor: ZYDUS PHARMS. Form: TABLET, FOR SUSPENSION. Route: ORAL

    full page →fda approvals ↗
    ›Mar 3, 2026approval165d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalACS Dobfar SpA

    Sponsor: ISTITUTO BIO ITA SPA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 3, 2026approval165d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalACS Dobfar SpA

    Sponsor: ISTITUTO BIO ITA SPA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 3, 2026approval165d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalACS Dobfar SpA

    Sponsor: ISTITUTO BIO ITA SPA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 3, 2026approval165d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalACS Dobfar SpA

    Sponsor: ISTITUTO BIO ITA SPA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 3, 2026approval165d agoBOSENTAN — FDA approvalBOSENTAN

    Sponsor: NATCO PHARMA LTD. Form: TABLET, FOR SUSPENSION. Route: ORAL

    full page →BOSENTAN →fda approvals ↗
    ›Mar 3, 2026approval165d agoBOSENTAN — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: AMNEAL PHARMS CO. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 3, 2026approval165d agoBOSENTAN — FDA approvalJanssen-Cilag Holdings Inc (Inactive)

    Sponsor: PH HEALTH. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 3, 2026approval165d agoFLUTICASONE PROPIONATE — FDA approvalFougera Pharmaceuticals Inc

    Sponsor: GLENMARK SPECLT. Form: AEROSOL, METERED. Route: INHALATION

    full page →fda approvals ↗
    ›Mar 3, 2026approval165d agoTRACLEER (BOSENTAN) — FDA approvalJanssen-Cilag Holdings Inc (Inactive)

    Sponsor: ACTELION. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 3, 2026approval165d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalACS Dobfar SpA

    Sponsor: ISTITUTO BIO ITA SPA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 3, 2026approval165d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalACS Dobfar SpA

    Sponsor: ISTITUTO BIO ITA SPA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 3, 2026approval165d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalACS Dobfar SpA

    Sponsor: ISTITUTO BIO ITA SPA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 3, 2026approval165d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalACS Dobfar SpA

    Sponsor: ISTITUTO BIO ITA SPA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 3, 2026approval165d agoBOSENTAN — FDA approvalBOSENTAN

    Sponsor: NATCO PHARMA LTD. Form: TABLET. Route: ORAL

    full page →BOSENTAN →fda approvals ↗
    ›Mar 3, 2026approval165d agoLETROZOLE — FDA approvalYiling Pharmaceutical Ltd

    Sponsor: PHARMOBEDIENT. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ← prev
    page 30 of 179
    next →
    $NSRX2.7000-1.82%
    $AMRX17.66+2.26%
    $NSRX2.7000-1.82%